Congress Seeks Assurances 340B Program Benefits Vulnerable Patients

An explanatory report on the appropriations bill suggests that the pharmaceutical industry is succeeding in efforts to convince Congress that the 340B drug discount program should be doing more to ensure patients directly benefit from the discounts.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America